Hodgkin's Lymphoma News and Research

Latest Hodgkin's Lymphoma News and Research

Researchers examine risk factors for B Cell Non-Hodgkin Lymphoma in Israeli, Palestinian populations

Israeli and Palestinian researchers have conducted a large scale epidemiological study examining risk factors for a form of Non-Hodgkin Lymphoma in these two populations.

21 Feb 2017

Research shows how protein component of Epstein-Barr virus promotes development of cancer

After an infection with the Epstein-Barr virus (EBV), the virus persists in the body throughout a person's lifetime, usually without causing any symptoms.

13 Feb 2017

New NCCN patient guide for Waldenström's Macroglobulinemia helps make informed treatment decisions

A very rare sub-type of Non-Hodgkin's Lymphoma, Waldenström's Macroglobulinemia affects approximately 1,500 - 2,000 people in the United States each year. While it is not curable, Waldenström's Macroglobulinemia is slow growing, and in many patients, manageable as a chronic disease.

6 Feb 2017

Prolonged exposure to work-related stress linked to increased risk of cancers

For men, prolonged exposure to work-related stress has been linked to an increased likelihood of lung, colon, rectal, and stomach cancer and non-Hodgkin lymphoma

17 Jan 2017

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

The National Comprehensive Cancer Network has published the NCCN Guidelines for Patients and NCCN Quick Guide sheets for Brain Cancer - Gliomas—the first in a series of patient education resources focused on Brain Cancer.

10 Jan 2017

Study shows promising results for treating lymphoma patients with immune cell therapy

Lymphoma is the most common blood cancer. The disease occurs when immune cells called lymphocytes multiply uncontrollably. Cancerous lymphocytes can travel throughout the body and form lymph node tumors.

6 Jan 2017

Cancers acquire resistance to immunotherapy by eliminating tumor-specific genetic mutations

Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic mutations needed to enable the immune system to recognize and attack malignant cells.

6 Jan 2017

Inherited CD70 deficiency increases susceptibility to Epstein-Barr virus and EBV-related cancer

Investigators at the National Institutes of Health and international colleagues have identified a genetic immune disorder characterized by increased susceptibility and poor immune control of Epstein-Barr virus (EBV) and, in some cases, an EBV-associated cancer called Hodgkin's lymphoma.

23 Dec 2016

Mayo Clinic creates genetic test to help guide diagnosis, treatment of lymphoma patients

Mayo Clinic has created a genetic test to help guide diagnosis and treatment of patients with diffuse large B-cell lymphoma, the most common type of non-Hodgkin's lymphoma.

16 Dec 2016

UNMC seeking patients with lymphoma to evaluate two-drug oral therapy

The University of Nebraska Medical Center is seeking 24 patients to enroll in a Phase 2a study to evaluate the safety and efficacy of two oral cancer drugs for patients with diffuse large B-cell lymphoma who have relapsed or are resistant to other traditional therapies.

9 Dec 2016

Dual therapy safe and effective in patients with recurrent Hodgkin lymphoma

The combination of two new drugs that harness the body's immune system is safe and effective, destroying most cancer cells in 64 percent of patients with recurrent Hodgkin lymphoma, according to the results of an early-phase study.

6 Dec 2016

Chemotherapy drug combination appears to increase production of eggs in women's ovaries

Women treated with a common chemotherapy drug combination have more young eggs in their ovaries afterwards, research has found.

6 Dec 2016

New report estimates global burden of cancer cases and deaths in 2015

In 2015, there were an estimated 17.5 million cancer cases around the globe and 8.7 million deaths, according to a new report from the Global Burden of Disease Cancer Collaboration published online by JAMA Oncology.

5 Dec 2016

Study finds lack of improvement in health status of childhood cancer survivors

Long-term survivors of childhood cancer live longer thanks to improvements to cancer treatments, but a new study looking at three decades of therapy suggests patients do not report better health status.

8 Nov 2016

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Amgen today announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the expanded use of ENBREL (etanercept), making it the first and only systemic therapy to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque psoriasis.

7 Nov 2016

Cancers that cause huge impact on healthy years of life linked to smoking and alcohol

A new study finds eleven of the 15 cancers with the most impact on healthy years of life lost in the United States are closely-associated with two preventable risk factors: smoking and alcohol.

18 Oct 2016

NCCN publishes new resources to help patients understand treatment options for stomach cancer

This year, it is estimated that more than 26,000 people will be diagnosed with Stomach Cancer in the United States, with nearly one million new cases diagnosed worldwide each year.

4 Oct 2016

Study suggests targeting UNG enzyme may help treat non-Hodgkin's lymphoma

Researchers have discovered that an enzyme called uracil-DNA glycosylase (UNG) protects the ends of B cell chromosomes to facilitate the proliferation of these antibody-producing cells in response to infection.

3 Oct 2016

Right dose of CAR T cells and lymphodepletion can achieve good response rates for NHL patients

In a paper published today in Science Translational Medicine, researchers from Fred Hutchinson Cancer Research Center shared data from an early-phase study of patients with advanced non-Hodgkin lymphoma (NHL) who received JCAR014, a Chimeric Antigen Receptor (CAR) T cell treatment, and chemotherapy.

9 Sep 2016

Blood cancer is associated with considerably higher healthcare costs than other cancers

Health economics studies, published today in The Lancet Haematology, report that the cost of treating blood cancers is twice that for treating other cancers. This is largely because they require more complex treatment regimens that necessitate longer hospital stays.

22 Jul 2016

Hodgkin's Lymphoma News and Research

Latest Hodgkin's Lymphoma News and Research

Researchers examine risk factors for B Cell Non-Hodgkin Lymphoma in Israeli, Palestinian populations

Research shows how protein component of Epstein-Barr virus promotes development of cancer

New NCCN patient guide for Waldenström's Macroglobulinemia helps make informed treatment decisions

Prolonged exposure to work-related stress linked to increased risk of cancers

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

Study shows promising results for treating lymphoma patients with immune cell therapy

Cancers acquire resistance to immunotherapy by eliminating tumor-specific genetic mutations

Inherited CD70 deficiency increases susceptibility to Epstein-Barr virus and EBV-related cancer

Mayo Clinic creates genetic test to help guide diagnosis, treatment of lymphoma patients

UNMC seeking patients with lymphoma to evaluate two-drug oral therapy

Dual therapy safe and effective in patients with recurrent Hodgkin lymphoma

Chemotherapy drug combination appears to increase production of eggs in women's ovaries

New report estimates global burden of cancer cases and deaths in 2015

Study finds lack of improvement in health status of childhood cancer survivors

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Cancers that cause huge impact on healthy years of life linked to smoking and alcohol

NCCN publishes new resources to help patients understand treatment options for stomach cancer

Study suggests targeting UNG enzyme may help treat non-Hodgkin's lymphoma

Right dose of CAR T cells and lymphodepletion can achieve good response rates for NHL patients

Blood cancer is associated with considerably higher healthcare costs than other cancers

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Hodgkin's Lymphoma News and Research

Latest Hodgkin's Lymphoma News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in